ArticleActa pharmaceutica Sinica. B2026

Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity.

Mingzhen Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.